Holen Sie sich die Stockscreener-App
1.26
1.61%
0.02
Handel nachbörslich:
1.28
0.02
+1.59%
Schlusskurs vom Vortag:
$1.24
Offen:
$1.27
24-Stunden-Volumen:
2.64M
Relative Volume:
0.61
Marktkapitalisierung:
$1.08B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-6.6316
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
-7.35%
1M Leistung:
-10.95%
6M Leistung:
-21.74%
1J Leistung:
-1.56%
1-Tages-Spanne:
$1.25
$1.28
1-Wochen-Bereich:
$1.21
$1.355
52-Wochen-Spanne:
$1.19
$2.035
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Vergleichen Sie OPK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.26 | 1.08B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
432.59 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
200.83 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.53 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
156.13 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-25 | Eingeleitet | JP Morgan | Neutral |
| 2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Bestätigt | Standpoint Research | Buy |
| 2016-06-03 | Eingeleitet | Standpoint Research | Buy |
| 2016-03-31 | Bestätigt | Barrington Research | Outperform |
| 2015-10-16 | Eingeleitet | JP Morgan | Overweight |
| 2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
| 2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Bestätigt | Oppenheimer | Outperform |
| 2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-10-22 | Eingeleitet | Barrington Research | Outperform |
| 2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
Renaissance Technologies LLC Has $215,000 Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times
Clinical Laboratory Tests Market Top PlayersARUP - openPR.com
Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com
Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN
Marshall Wace LLP Has $1.36 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Invesco Ltd. Has $2.29 Million Stake in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Piper Sandler Keeps Their Buy Rating on Opko Health (OPK) - The Globe and Mail
OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript - Insider Monkey
Weekly CEO Buys Highlight - GuruFocus
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Update - MarketBeat
OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Yahoo Finance
Quote - OPKO Health, Inc.
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast By Investing.com - Investing.com South Africa
OPKO Health Reports Q1 2025 Financial Highlights - TipRanks
OPKO Health: Q1 Earnings Snapshot - MySA
OPKO Health Inc Q1 2025 Earnings: EPS Misses at -$0.10, Revenue Falls Short at $149.9 Million - GuruFocus
OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com
Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com
OPKO Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewswire
OPKO Health Q1: $225M Oncology Asset Sale to Labcorp Plus New Oral GLP-1 Program Launch - Stock Titan
OPKO Health (NASDAQ:OPK) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
OPKO Health (OPK) to Release Earnings on Wednesday - MarketBeat
Pediatric Growth Hormone Deficiency Treatment Market Size - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN
Analyst Expectations For OPKO Health's Future - Benzinga
JPMorgan starts Opko Health stock with Neutral rating By Investing.com - Investing.com India
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):